Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nbaa Masood & Joohi Jimenez-Shahed. (2023) Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs. Neuropsychiatric Disease and Treatment 19, pages 247-266.
Read now
Read now
Peter Jenner, José-Francisco Rocha, Joaquim J Ferreira, Olivier Rascol & Patrício Soares-da-Silva. (2021) Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone. Expert Review of Neurotherapeutics 21:9, pages 1019-1033.
Read now
Read now
Articles from other publishers (1)
K. Ray Chaudhuri, A. Simon Pickard, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Yanjun Bao, Julia Sus, Glynn Jones, Christian Ridley, Julia Oddsdottir, Seyavash Najle-Rahim, Matthew Madin-Warburton, Weiwei Xu & Anette Schrag. (2022) The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England. PharmacoEconomics 40:5, pages 559-574.
Crossref
Crossref